Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages (Q43036009)

12 November 2017

title

Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages (English)

1 reference

12 November 2017

1 reference

David M Lewinsohn

0 references

Hugo R Rosen

1 reference

12 November 2017

Camette Miner

1 reference

12 November 2017

Anna W Sasaki

1 reference

12 November 2017

Andrew J Conrad

1 reference

12 November 2017

Antony Bakke

1 reference

12 November 2017

H G Archie Bouwer

1 reference

12 November 2017

David J Hinrichs

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

12 November 2017

1 reference

12 November 2017

1 reference

12 November 2017

1 reference

12 November 2017

page(s)

190-198

1 reference

describes a project that uses

12 November 2017

1 reference

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Primer on hepatitis C for hospital epidemiologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Replication of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Viral hepatitis in the liver transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

T-lymphocyte response to hepatitis C virus in different clinical courses of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Superantigens - powerful modifiers of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Virology of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Viral immune evasion due to persistence of activated T cells without effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Analysis of a successful immune response against hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Immunopathogenesis of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Strange brew: T cells in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.30293

21 January 2018

Identifiers

DOI

10.1053/JHEP.2002.30293

1 reference

12 November 2017

1 reference